[Long-term clinical experiences with the cation exchanger UJOLYT as a metaphylactic in absorptive hypercalciuria and chronic recurring calcium oxalate lithiasis].
The UJOLYT cation exchange was checked in a clinically controlled study over a long period using 6 male test persons with chronically recidive calcium oxalate lithiasis and absorptive hypercalciuria. The PAK calcium load test proved clinically valuable in the differentiation of idiopathic hypercalciuria. The paraclinical findings revealed an average reduction of urinary calcium excretion by 40% and an increase of urinary magnesium excretion by 11.7% compared to the initial situation. The recidive frequency was clearly reduced. No serious side-effects were observed in the patients presented.
D000328:Adult; D002118:Calcium / Q000652:urine*; D002129:Calcium Oxalate / Q000652:urine*; D002411:Cation Exchange Resins / Q000627:therapeutic use*; D004573:Electrolytes / Q000652:urine; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects*; D007475:Ion Exchange Resins / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011108:Polymers / Q000627:therapeutic use*; D012008:Recurrence; D014545:Urinary Calculi / Q000517:prevention & control* / Q000652:urine
D002411:Cation Exchange Resins; D004573:Electrolytes; D007475:Ion Exchange Resins; D011108:Polymers; D002129:Calcium Oxalate; C039321:Ujolyt; D002118:Calcium
Klinische Langzeiterfahrungen mit dem Kationenaustauscher UJOLYT als Metaphylaktikum bei absorptiver Hyperkalziurie und chronisch-rezidivierender Kalziumoxalatlithiasis.